肝病病理学:近50年进展
本文回顾肝病病理学近50年的发展,指出组织学、免疫染色、高分辨率影像、活检与切除方法改进及分子时代是主要驱动力;学科从基于观察的模式分类转向以病因和肿瘤分类为核心的精细分类,并以肝特异性疾病举例说明。
要点
- 肝病病理分类已从观察性模式分类转向基于病因与肿瘤学的精细分类。
- 组织学、免疫染色、高分辨率影像、活检与切除方法改进及分子时代共同推动进展。
- 肝病理通过疾病识别与分类继续改善患者照护,并在指导治愈性治疗中发挥作用。
核心结论
- 肝病病理学近50年取得显著进展,分类体系转向基于病因与肿瘤学的精细分类。
研究设计与样本
- 综述性回顾,梳理肝病病理学近50年的进展与驱动因素。
主要发现
- 组织学、免疫染色、高分辨率影像、活检与切除方法改进及分子时代共同推动肝病病理学发展。
- 肝病病理分类从观察性、模式化方法转向精细分类,医学疾病按病因、肿瘤性疾病按肿瘤分类。
- 肝病理通过疾病识别与分类改善患者照护,并在指导治愈性治疗中具有新兴作用。
临床怎么用
- 病理科医生应理解肝病分类已转向病因与肿瘤分类框架,并结合免疫染色与分子工具辅助诊断。
- 肝病理在疾病识别、分类及指导治疗方面具有临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver disease has been recognized in various forms for centuries. Incredible advances, however, have been made especially in the last 50 years, driven by improvements in histology, the development of immunostains, the development of high resolution imaging methods, improved biopsy and resection methods, and the emergence of the molecular era. With these tools, pathologists and their clinical and basic science colleagues moved from classifying liver disease using an observational, pattern-based approach to a refined classification of disease, one based on etiology for medical disease and tumor classification for neoplastic disease. Examples of liver specific diseases are used to illustrate these exciting advances. These impressive advances of the past provide the foundation for hope in the future, as liver pathology continues to play an important role in improving patient care through disease identification and classification and emerging roles in guiding therapy for cures.
引用
- Torbenson M, Washington K. Pathology of liver disease: advances in the last 50 years. Hum Pathol. 2019. PMID: 31493428. doi:10.1016/j.humpath.2019.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。